A Phase 1 feasibility study of iron oxide nanoparticle hyperthermia in stage 4 solid tumors
Recruiting Not Applicable NCT07224464
Study Description
Early safety study testing heated magnetic nanoparticles to treat advanced cancer that hasn't responded to standard treatments
Study Details
- Registry ID:
- NCT07224464
- Conditions:
- Metastatic Solid Tumors, Stage 4 Cancer
- Phase:
- Not Applicable
- Target Enrollment:
- 12 participants
- Start Date:
- Age Range:
- 18–999 years
- Healthy Volunteers:
- No
Study Locations (1 site)
-
Mayo Clinic
Rochester, Minnesota, United States
Interested in Participating?
Check your eligibility and learn more about this study on TrialScreen.